08:00 , Mar 5, 2012 |  BC Week In Review  |  Clinical News

Cell-based Potency Assay regulatory update

Allergan said 2 regulatory agencies issued positive opinions for approval of its Cell-based Potency Assay (CBPA) to test the stability and potency of the company's Botox /Vistabel onabotulinumtoxinA. Ireland acted as reference member state under...
07:00 , Jul 4, 2011 |  BC Week In Review  |  Clinical News

Botox Cell-based Potency Assay regulatory update

FDA approved Allergan's Botox Cell-based Potency Assay (CBPA) to test the stability and potency of the company's Botox onabotulinumtoxinA and Botox Cosmetic. The assay, which will be launched in the U.S. immediately, is the first...